Paper648557
Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.
Noel G and 3 others. Eur J Cancer (1965), 1978. Cited by 104 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. Papers, record 648557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/648557
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Fibroblasts | Major topic |
| Animals | |
| Cell Nucleus | |
| Cells, Cultured | |
| Kinetics | |
| Lysosomes | |
| Rats | |
| Subcellular Fractions | |
| Time Factors |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,155,892 | Lysosomal Drug Sequestration Mediated by ABC Transporters and Drug Resistance. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155892 | PubMed |
| 36,899,844 | What Is the Significance of Lysosomal-Mediated Resistance to Imatinib? | Cells | 2023 | https://conductscience.org/library/papers/36899844 | PubMed |
| 31,683,643 | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance. | Biomolecules | 2019 | https://conductscience.org/library/papers/31683643 | PubMed |
| 22,563,426 | Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin. | PLoS One | 2012 | https://conductscience.org/library/papers/22563426 | PubMed |
| 10,070,878 | The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10070878 | PubMed |
| 6,961,971 | Uptake and metabolism of daunorubicin by human leukemia cells. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6961971 | PubMed |
| 6,958,392 | Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6958392 | PubMed |
| 6,941,824 | Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells. | Blut | 1981 | https://conductscience.org/library/papers/6941824 | PubMed |
| 6,733,840 | Cytofluorescence localization of adriamycin in resistant colon cancer cells. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6733840 | PubMed |
| 6,690,077 | Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6690077 | PubMed |
| 6,627,597 | Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6627597 | PubMed |
| 6,446,523 | Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw. | Inflammation | 1980 | https://conductscience.org/library/papers/6446523 | PubMed |
| 4,054,202 | Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4054202 | PubMed |
| 4,006,046 | Lysosomal alterations in heart and liver of mice treated with doxorubicin. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4006046 | PubMed |
| 3,770,010 | Hepatic metabolism of doxorubicin in mice and rats. | Eur J Drug Metab Pharmacokinet | 1986 | https://conductscience.org/library/papers/3770010 | PubMed |
| 3,742,710 | Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3742710 | PubMed |
| 3,579,258 | Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3579258 | PubMed |
| 3,466,179 | Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3466179 | PubMed |
| 2,295,112 | Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2295112 | PubMed |
| 2,254,382 | Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time. | J Cancer Res Clin Oncol | 1990 | https://conductscience.org/library/papers/2254382 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/648557
GET https://conductscience.org/api/papers/v1/648557/cited_by?page=2